You are here



Note from CERID Director Wes Van Voorhis

Infectious Diseases are a primary cause of death and disability, affecting hundreds of millions worldwide. Malaria, HIV/AIDS, tuberculosis, diarrheal diseases, hepatitis, and others comprise more than a third of all causes of premature death (see figure below) and it is a tragic fact that these pathogens have an outsized effect on the developing world. The new Center for Emerging and Re-emerging Infectious Diseases (CERID) is composed of infectious disease researchers grouped together for collaboration and synergy at the University of Washington's South Lake Union medical research campus.

Already experts in their respective fields of immunology, pathogenesis, drug discovery, translational research, and more; CERID researchers are poised to continue making great strides in our understanding of not only the pathogens and agents that cause these ongoing epidemics, but also their transmission mechanisms and vulnerabilities. In hopes of lowering infection rates and improving public health, drug and vaccine development is a core goal of CERID. 

Though the CERID structure will help the interplay of investigators to collaborate on pathogens already under study, the novel part of this center is that this group of infectious disease researchers can opportunistically tackle new pathogens as they emerge on the world stage. SARS, West Nile Virus, new influenza strains, and other emerging diseases will require rapid study and and cross-disciplinary collaboration to prevent and manage new epidemics. CERID experts are equipped with the knowledge, skills and equipment to make this difference.  

Your gift can help - each donation helps CERID to fund new studies, equipment and experts to meet the existing and emerging ID challenges, benefiting humankind by producing outstanding and timely research.


Wesley C. Van Voorhis, MD, PhD